Trial intelligence / Profile preview

Safety of CHF 1535 in Asthmatic Children

NCT01450774Phase 3Completed

Sponsor
Chiesi Farmaceutici S.p.A.
Start
Sep 2011
Primary completion
Nov 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of beclomethasone dipropionate, formoterol in asthma, sponsored by Chiesi Farmaceutici S.p.A.. Started Sep 2011; status: completed.

02

Drugs

beclomethasone dipropionateformoterol
03

Conditions

asthma

Beyond the preview

Go deeper on NCT01450774.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01450774.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call